Targeted Treatments for Breast Cancer by Dr Elaine Vickers

25 May 2017
Manchester, United Kingdom
 

Facilitator - Dr Elaine Vickers

Dr Elaine Vickers, Science Communicated Ltd’s Founder and Principal Trainer, has a Degree in

Medical Science, a PhD in Molecular Biology and over ten years experience in communicating science to a wide range of audiences.

She has worked as a science communicator for three of the UK’s leading medical research charities, including four years in the Science Information team at Cancer Research UK.

When training, Elaine’s energetic and approachable style ensures that delegates not only gain new knowledge and insight, but also have a hunger to learn more.

Topics

- Introduction to cancer cell biology & genetics

- Concepts relating to drug resistance: the cancer microenvironment, cancer stem cells, genomic instability, intra-tumoural  heterogeneity

- Faulty genes, proteins, pathways & processes in breast cancer cells

- The theory behind standard treatments:  chemotherapy, radiotherapy and hormone therapy

- HER2: what it is, what it does and how to block it

- The importance of the PI3K/AKT/mTOR  pathway in breast cancer & new PI3K inhibitors

- The use of PARP inhibitors for BRCA-mutated breast cancer

- Novel targets and treatments e.g. CDK inhibitors and immunotherapy

Target Audience

Research nurses, clinical nurse specialists,
chemotherapy/out-patient cancer nurses,
pharmacists, clinical trials coordinators and other trials staff, medical writers and medical advisors in the pharmaceutical industry. Elaine presumes that you will have a basic knowledge of cells and DNA but pre-course reading will be sent out to
familiarise participants with some of the scientific concepts covered during the day

Fees

£100 (NHS staff)

£200 (Non-NHS staff) 

Related Events

Comments